pdufa.bio

TAUKLARIFY (florquinitau F 18, MK-6240)

Updated ยทnext FDA decision on the calendar

TAUKLARIFY (florquinitau F 18, MK-6240) 1 FDA decision on record below. Every date links its source.

LNTH catalyst hub

About this program

We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

PDUFA · Aug 13, 2026 ✓ ApprovedLNTH

Questions

When is TAUKLARIFY (florquinitau F 18, MK-6240)'s next FDA decision or readout?

No upcoming catalyst is on our calendar for TAUKLARIFY (florquinitau F 18, MK-6240); 1 FDA decision is on record below.

What happened at TAUKLARIFY (florquinitau F 18, MK-6240)'s most recent FDA decision?

On Aug 13, 2026 the FDA approved the application. The decision page carries the source document and the measured share-price reaction.

Has TAUKLARIFY (florquinitau F 18, MK-6240) been approved by the FDA?

Yes. The FDA approved an application for TAUKLARIFY (florquinitau F 18, MK-6240) on Aug 13, 2026; the decision page linked above carries the source.

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.